| Financial Year |
March 31 2023 |
| Monetary Funds |
3,250,919,593.87 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
59,562,289.32 |
| Accounts Receivable |
954,059,088.54 |
| Advances to Suppliers |
557,621,852.65 |
| Other Receivables |
652,387,162.10 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,712,264,343.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
248,947,748.45 |
| Other Current Assets |
247,506,594.33 |
| Total Current Assets |
12,525,744,948.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
466,128,544.38 |
| Long-term Equity Investment |
333,161,895.09 |
| Investment Properties |
150,346,154.32 |
| Fixed Assetes |
17,295,922,160.74 |
| Under-construction Projects |
1,651,499,184.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,419,176,234.34 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,335,986,617.88 |
| Deferred Income Tax Assets |
254,270,951.87 |
| Other Non-Current Assets |
40,758,662.00 |
| Sub-Total of Non-Current Assets |
25,273,002,057.52 |
| Total Assets |
37,798,747,006.08 |
| Short-Term Loans |
2,219,112,809.21 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,656,754,777.15 |
| Accounts Received In Advance |
581,629.00 |
| Employee Compensation Payable |
158,689,514.22 |
| Taxes Payable |
169,186,766.56 |
| Interest Payable |
-- |
| Dividend Payable |
8,291,500.81 |
| Other payables |
607,442,047.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,673,675,532.19 |
| Other Current Liabilities |
71,151,809.25 |
| Sub-Total of Current Liabilities |
10,062,723,777.40 |
| Long-term Loans |
8,474,292,360.47 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
490,386,011.17 |
| Special Payable |
-- |
| Estimatied Liabilities |
89,557,720.33 |
| Deferred Income Tax Liabilities |
248,113,368.41 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,990,593,890.62 |
| Total Liabilities |
20,053,317,668.02 |
| Paid-In Capital(Or Share Stock) |
1,645,801,952.00 |
| Capital Surplus |
8,320,675,403.17 |
| Surplus Reserve |
533,649,156.73 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,344,289,944.81 |
| Minority Stockholder's Interest |
941,695,241.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
16,803,734,096.20 |
| Owner's Equity（Stockholder's Equity） |
17,745,429,338.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
37,798,747,006.08 |
